The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
AIRPanc: A phase 2, open-label, multicenter, randomized study evaluating neoadjuvant therapy targeting the adenosine immunosuppressive pathway in combination with immune checkpoint blockade and radiation therapy in patients with advanced pancreatic ductal adenocarcinoma who are candidates for surgical resection.
 
Gulam Abbas Manji
Honoraria - Celgene; Cend Therapeutics; Exelixis; Roche/Genentech
Consulting or Advisory Role - Cend Therapeutics; Exelixis; Ipsen; Roche/Genentech
Research Funding - Arcus Biosciences (Inst); BiolineRx (Inst); Merck (Inst); Plexxikon (Inst); Regeneron (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Celgene; Exelixis; Roche/Genentech
 
Brian William Labadie
No Relationships to Disclose
 
Jacob K. Jamison
No Relationships to Disclose
 
Linda Wu
No Relationships to Disclose
 
Shikun Wang
No Relationships to Disclose
 
Ilenia Pellicciotta
No Relationships to Disclose
 
Sarah Sta Ana
No Relationships to Disclose
 
Naomi Sender
No Relationships to Disclose
 
Isabelle Ross
No Relationships to Disclose
 
Hope Cho
No Relationships to Disclose
 
David Paul Horowitz
Research Funding - Varian Medical Systems (Inst)
 
John A. Chabot
Employment - Columbia University
Stock and Other Ownership Interests - MORE Health; RadioClash